BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9605005)

  • 1. Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.
    Hlavatý J; Hlubinová K; Altanerová V; Líska J; Altaner C
    Neoplasma; 1997; 44(6):342-7. PubMed ID: 9605005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
    Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
    J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.
    Hlavatý J; Hlubinová K; Bies J; Altaner C
    Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene.
    Ezzeddine ZD; Martuza RL; Platika D; Short MP; Malick A; Choi B; Breakefield XO
    New Biol; 1991 Jun; 3(6):608-14. PubMed ID: 1655012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging.
    Maron A; Gustin T; Le Roux A; Mottet I; Dedieu JF; Brion JP; Demeure R; Perricaudet M; Octave JN
    Gene Ther; 1996 Apr; 3(4):315-22. PubMed ID: 8732163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
    Okada H; Attanucci J; Tahara H; Pollack IF; Bozik ME; Chambers WH; Lotze MT
    Cancer Gene Ther; 2000 Mar; 7(3):486-94. PubMed ID: 10766355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
    Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
    Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
    Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
    Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
    Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
    Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
    Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
    Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
    Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
    Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
    Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
    Walling HW; Swarthout JT; Culver KW
    Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.